Unprecedented FDA Testing Secures Confidence in US Infant Formula Supply

Washington, Wednesday, 29 April 2026.
Analyzing over 120,000 data points from 300 products, the FDA’s largest-ever infant formula study confirms exceptionally low contaminant levels, ensuring critical market stability and consumer safety.